Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Lorvotuzumab mertansine evaluated in patients with solid tumors

Oct. 2, 2012

Stem cell gene therapy shows promise in mucopolysaccharidosis IIIA model

Oct. 1, 2012

Phase I data on veliparib in patients with brain metastases reported

Oct. 1, 2012

Further clinical data reported on cancer vaccine MGN-1601 at ESMO

Oct. 1, 2012

Kalidex conducts phase I study of novel fluoroquinolone antibiotic

Sep. 28, 2012

New DNA supercoiling inhibitors for bacterial infections presented by Biota

Sep. 28, 2012

EE-TP shows promise for the treatment of MNGIE

Sep. 28, 2012

Teijin Pharma describes novel anticoagulant molecules

Sep. 27, 2012

Beta-amyloid 17 identified as a potential blood biomarker of early Alzheimer's disease

Sep. 27, 2012

Minicircle plasmid DNA vector successfully treats liver disease in mice

Sep. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026